Role of HPV testing in the follow-up of women treated for cervical dysplasia

Archives of Gynecology and Obstetrics

Volumn 282, Issue 2, 2010, Pages 193-197

  Ribaldone, Raffaella ^a   Boldorini, Renzo ^a,b   Capuano, Andrea ^a   Arrigoni, Silvia ^a   Di Oto, Alessia ^a   Surico, Nicola ^a  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Cervical conisation; Cervical dysplasia; HPV; HPV testing; PCR

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COLPOSCOPY; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GENOTYPE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREDICTION; RECURRENCE RISK; RECURRENT CANCER; RISK ASSESSMENT; STRAIN IDENTIFICATION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX CYTOLOGY; VIRUS CHARACTERIZATION; VIRUS DIAGNOSIS; VIRUS IDENTIFICATION; VIRUS TYPING; WART VIRUS; WOMEN'S HEALTH; ISOLATION AND PURIFICATION; LOW LEVEL LASER THERAPY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SQUAMOUS CELL; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; TREATMENT OUTCOME; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY; YOUNG ADULT;

ADULT; AGED; CONIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER THERAPY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SQUAMOUS CELL; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TREATMENT OUTCOME; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 77956467876     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-009-1316-5     Document Type: Article

References (27)

1. Haverkos HW (2005) Multifactorial etiology of cervical cancer: a hypothesis. Med Gen Med 7:57
2. Behtash N, Mehrdad N (2006) Cervical cancer: screening and prevention. Asian Pac J Cancer Prev 7:683-686
3. Boulet GA, Horvath CA, Berghmans S, Bogers J (2008) Human papillomavirus in cervical cancer screening: important role as biomarker. Cancer Epidemiol Biomarkers Prev 17:810-817
4. Marchetti I, Zavaglia K, Bertacca G, Aretini P, Matteoli B, Viacava P, Prato B, De Punzio C, Genazzani AR, Bevilacqua G, Di Coscio G (2006) HPV testing and Pap test: role for a combined approach in a non-screened population. Int J Biol Markers 21:149-156
5. You K, Liang X, Qin F, Guo Y, Geng L (2007) High-risk human papillomavirus DNA testing, high-grade cervical intraepithelial lesions. Aust N Z J Obstet Gynaecol 47:141-144
6. Paraskevaidis E, Arbyn M, Sotiriadis A, Diakomanolis E, Martin-Hirsch P, Koliopoulos G, Makrydimas G, Tofoski J, Roukos D (2004) The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev 30:205-211
7. Melnikow J, Nuovo J, William AR, Chan BK, Howell LP (1998) Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 92:727-735
8. Chew GK, Jandial L, Paraskevaidis E, Kitchener HC (1999) Pattern of CIN recurrence following laser ablation treatment: long-term follow-up. Int J Gynecol Cancer 9:487-490
9. Soutter WP, De Barros Lopes A, Fletcher A, Monaghan JM, Duncan ID, Paraskevaidis E, Kitchener HC (1997) Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 349:978-980 (Pubitemid 27149800)
10. Gok M, Coupè VM, Berkhof J, Verheijen RH, Helmerhost TJ, Hogewoning CJ, Snijders PJ, Meijer CJ (2007) HPV 16 and increased risk of recurrence after treatment for CIN. Gynecol Oncol 104:273-275
11. Venturoli S, Ambretti S, Cricca M, Leo E, Costa S, Musiani M, Zerbini M (2008) Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment. J Med Virol 80:1434-1440
12. Riethmuller D, Gabelle C, Ramanah R, Sautière JL, Prètet JL, Schaal JP, Kantelip B, Mougin C, Maillet R (2008) Importance of human papillomavirus (HPV) screening in the follow-up after CIN2-3 treatment. J Gynecol Obstet Biol Reprod (Paris) 37:329-337
13. Aerssens A, Claeys P, Garcia A, Sturtewagen Y, Velasquez R, Vanden Broeck D, Vansteelandt S, Temmerman M, Cuvelier CA (2008) Natural history and clearance of HPV after treatment of precancerous cervical lesions. Histopathology 52:381-386
14. Von Keyserling H, Kaufmann AM, Schneider A (2007) HPV testing in the follow-up after treatment of women with CIN. Gynecol Oncol 107: S5-S7
15. Bourgault-Villada I (2007) Anti human-papillomavirus vaccines: concepts, aims and trials. Rev Med Interne 28:22-27
16. Chardonnet Y, Bèjui-Thivolet F, Viac J (1992) Malpighian epithelia and papillomavirus infections. Pathol Biol (Paris) 40:247-256
17. Carozzi FM, Confortini M, Cecchini S, Bisanzi S, Cariaggi MP, Pontenani G, Raspollini MR, Sani C, Zappa M, Ciatto S (2005) Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment. Cancer 105:2-7
18. Andersson S, Dillner L, Elfgren K, Mints M, Persson M, Rylander E (2005) A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities. Acta Obstet Gynecol Scand 84:996-1000
19. Dalla Palma P, Pojer A, Girlando S (2005) HPV triage of women with atypical squamous cells of undetermined significance: a 3-year experience in an Italian organized programme. Cytopathology 16:22-26
20. Aerssens A, Claeys P, Beerens E, Garcia A, Weyers S, Van Renterghem L, Praet M, Temmerman M, Velasquez R, Cuvelier CA (2009) Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia. Cytopathology 20:27-35
21. Zielinski GD, Bais AG, Helmerhost TJ, Verheijen RH, de Schipper FA, Snijders PJ, Voorhorst FJ, van Kemenade FJ, Rozendaal L, Meijer CJ (2004) HPV testing and monitoring of women after treatment of CIN3: review of the literature and meta-analysis. Obstet Gynecol Surv 59:543-553
22. Kitchener HC, Cruickshank ME, Farmery E (1995) The 1993 British society for colposcopy, cervical pathology/national coordinating network United Kingdom colposcopy survey. Comparison with 1988 and the response to introduction of guidelines. Br J Obstet Gynaecol 102:549-552
23. Bozanovic T, Ljubic A, Momcilov P, Milicevic S, Mostic T, Atanackovic J (2008) Cold-knife conization versus the loop electrosurgical excision procedure for treatment of cervical dysplasia. Eur J Gynaecol Oncol 29:83-85
24. Kalliala I, Nieminen P, Dyba T, Pukkala E, Anttila A (2007) Cancer free survival after CIN treatment: comparisons of treatment methods and histology. Gynecol Oncol 105:228-233
25. Kalliala I, Anttila A, Pukkala E, Nieminen P (2005) Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ 331:1183-1185
26. Strander B, Andersson-Ellstrom A, Milson I, Sparen P (2007) Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. BMJ 335:1077
27. Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W (2006) Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. BJOG 113:1303-1307